Jim Simons Corcept Therapeutics Inc Call Options Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CORT
# of Institutions
347Shares Held
86.6MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$979 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$592 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$489 Million14.93% of portfolio
-
Parallel Advisors, LLC3.81MShares$226 Million4.22% of portfolio
-
State Street Corp Boston, MA3.52MShares$208 Million0.01% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.34B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...